Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2011 09:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces 2010 Year End Financial Results Conference Call

SAN DIEGO, March 9, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that management will hold a conference call to discuss its 2010 year end financial...
March 08, 2011 09:57 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Removal of Auditor's "Going Concern" Opinion From Its 2010 Form 10-K and Increased Cash Reserves

SAN DIEGO, March 8, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that the going concern paragraph has been removed from its audit opinion contained...
March 01, 2011 09:14 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

SAN DIEGO, March 1, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that the European Patent Office ("EPO") will grant a patent for the company's...
February 17, 2011 09:11 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and FDA Initiate PrevOnco(TM) SPA Phase III Clinical Protocol Discussion

SAN DIEGO, Feb. 17, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that it is currently in discussions with the U.S. Food and Drug Administration...
February 14, 2011 10:14 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties

SAN DIEGO, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that it has entered into a licensing agreement granting Neopharm Group...
February 10, 2011 10:14 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present Review of Commercialization Plans for Vitaros(R) and Development of Product Pipeline at BioPartnering North America Conference(TM)

SAN DIEGO, Calif., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), (http://www.apricusbio.com) today announced that Linda Smibert, Vice President, Business...
January 28, 2011 09:52 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Presents Data on Oral Use of Nexact(R) Technology at the Controlled Release Society Conference

SAN DIEGO, Jan. 28, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), (http://www.apricusbio.com) today announced that its research and development team at its...
January 26, 2011 10:02 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' Chief Executive Officer is Interviewed on CDTV.net

SAN DIEGO, Jan. 26, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chief Executive Officer, Dr. Bassam...
January 19, 2011 11:41 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Therapy, Loceryl(R)

SAN DIEGO, Jan. 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) today announced that an additional analysis conducted on behalf of the Company has shown that...
January 14, 2011 12:03 ET | Source: Seelos Therapeutics, Inc.

Apricus Bio Announces Expansion of Patent Portfolio for Topical Cream to Treat Premature Ejaculation With Issuance of Japanese Patent

SAN DIEGO, Jan. 14, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc., ("Apricus Bio") (Nasdaq:APRI) today announced that the Japanese Patent Office recently issued a Decision to Grant a Patent for...